97155 ⎘
Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
Diagnostic assay and method of treatment for miscarriage risk or premature birth involving macrophage inhibitory cytokine-1 (MIC-1)
#902MODULATING ANGIOGENESIS
#903Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8 associated disorders
#904Method for treating rheumatoid arthritis using anti-S100A9 antibody
#905Inhibition of urokinase-type plasminogen activator (uPA) activity
#906ATTENUATION OF HYPOXIA INDUCED CARDIOVASCULAR DISORDERS
#907Antagonists of HMG1 for treating inflammatory conditions
#908Methods for Treating Autoimmune Diseases in a Subject and In Vitro Diagnostic Assays
#909Methods and Compositions for Using MHC Class II Invariant Chain Polypeptide as a Receptor for Macrophage Migration Inhibitory Factor
#910Transgenic animals expressing chimeric antibodies for use in preparing human antibodies
#911Cerebral Infarction Suppressant
#912Human Endokine Alpha and Methods of Use
#913Antigen binding proteins capable of binding thymic stromal lymphopoietin
#914Method of inhibiting human G-protein chemokine receptor (CCR5) HDGNR10
#915NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#916Anti MIF Antibodies
#917Murine zcytor17 ligand polypeptides
#918MAMMALIAN CHEMOKINE REAGENTS
#919Organic compounds
#920Method of preventing cerebral vasospasm with anti-HMGB1 antibody
#921METHODS OF INHIBITING METASTASIS
#922Neutrokine-alpha antibodies and methods of use thereof
#923Anti-IP-10 antibodies and methods of use thereof
#924High affinity antibodies against HMGB1 and methods of use thereof
#925Antibodies to ZCYTO20 (IL-28A) and ZCYTO22 (IL-28B)
#926Antibodies to human zcytor17 ligand
#927PREVENTIVE OR THERAPEUTIC AGENT CONTAINING ANTI THIOREDOXIN ANTIBODY POLYPEPTIDE AS AN ACTIVE INGREDIENT FOR DISORDERS
#928Anti-RANTES antibodies
#929Monoclonal antibodies against HMGB1
#930Therapeutic composition for use in the prevention and treatment of bone metastases
#931Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
#932Compositions and methods for diagnosis and treatment of tumors
#933CXCL13 Antagonists and Their Use for the Treatment of Inflammatory Diseases
#934Use of TRAIL polypeptides to induce apoptosis
#935Method of diagnosis of inflammatory disease using eotaxin antibodies
#936NEUTROKINE-ALPHA AND NEUTROKINE-ALPHA SPLICE VARIANT
#937Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
#938Use of Antagonists of Cxcl13 or Cxcr5 for Treating Wounds of Fibrotic Diseases
#939AGENT FOR PROMOTING HEPATIC CELL REPLICATION AND AGENT FOR IMPROVING INSULIN RESISTANCE
#940Nucleic acids encoding ChemerinR ligands
#941Methods of treatment using antibodies to neutrokine-alpha
#942Anti-MCP-1 antibodies, compositions, methods and uses
#943Humanized anti-human osteopontin antibody
#944Compositions comprising a ligand of Chemerin R
#945Antibodies Against Human G-Protein Chemokine Receptor (CCR5) HDGNR10
#946Vascular endothelial growth factor 2
#947Antibodies that inhibit TSLP activity
#948Antibodies against monocyte chemotactic proteins
#949ANTIBODY VARIANTS
#950Method for modulating appetite
#951Therapeutic uses of factors which inhibit or neutralize MIF activity
#952Diagnostic test for inflammatory endothelial dysfunctions in pregnancies
#953Antagonists of Hmgb1 and/or Rage and Methods of Use Thereof
#954Vascular endothelial cell growth factor antagonists and uses thereof
#955Treatment Of Type 1 Diabetes With Inhibitors Of Macrophage Migration Inhibitory Factor
#956Methods And Compositions For The Treatment Of Ocular Neovascularization
#957Vascular endothelial cell growth factor antagonists and uses thereof
#958Antibody Variants with Faster Antigen Association Rates
#959Chemokine panec-1 antibodies
#960Vascular endothelial growth factor 2
#961Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
#962Myeloid progenitor inhibitory factor-1 (MPIF-1) polypeptides
#963NOVEL COMPOUNDS
#964Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
#965Methods of treating arthritic conditions with antibodies to M-CSF
#966Bispecific antibody targeting a complement factor or complement regulatory protein
#967METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#968Antibodies that specifically bind to chemokine β-4
#969CXCL13 binding proteins
#970METHOD OF MODULATING NEUTRALIZING ANTIBODIES FORMATION IN MAMMALS, AND USES THEREOF IN GENE THERAPY, ANIMAL TRANGENESIS AND IN FUNCTIONAL INACTIVATION OF ENDOGENOUS PROTEINS
#971COMPOUNDS
#972Polypeptides, polynucleotides and uses thereof
#973Method for preventing HIV-1 infection of CD4 cells
#974Methods of obtaining a specific binding member that binds eotaxin
#975HMGB1 protein inhibitorsand/or antagonists for the treatment of vascular diseases
#976Nucleic acid encoding human antibodies specific for interleukin 15 (IL-15)
#977Method for treating psoriasis by administering human antibodies specific for Interleukin 15 (IL-15)
#978Inhibition of osteopontin for treatment of relapsing autoimmune disease
#979Canine thymic stromal lymphopoietin protein and uses thereof
#980Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factor
#981Cytokine protein family
#982Method of treating a pathological syndrome and a pharmaceutical agent
#983Diagnosis and treatment O prostate cancer
#984Monoclonal antibodies against HMGB1
#985METHODS AND COMPOSITIONS FOR IMMUNOTHERAPY AND DETECTION OF INFLAMMATORY AND IMMUNE-DYSREGULATORY DISEASE, INFECTIOUS DISEASE, PATHOLOGIC ANGIOGENESIS AND CANCER
#986Antibodies against inducible TH2 cell factors
#987Method of using interferon-like protein ZCYTO20 (IL-28A) or ZCYTO22 (IL-28B) to treat hepatitis C
#988Combination Therapies Of Hmgb And Complement Inhibitors Against Inflammation
#989Method of treating fibrosis
#990Antibodies to human eotaxin
#991ANTI-OSTEOPONTIN ANTIBODY AND USE THEREOF
#992Methods of treating tendonitis in a subject by using an anti-cytokine agent
#993Treatment of inflammatory bowel diseases with anti-IP-10 antibodies
#994Method of increasing trafficking of endothelial progenitor cells to ischemia-damaged tissue
#995Method of treating a pathological syndrome and a pharmaceutical agent
#996Method of treating a pathological syndrome and a pharmaceutical agent
#997MAMMALIAN CHEMOKINE REAGENTS
#998Inflammatory mediator antagonists
#999Tus DNA binding domains
#1000Cytokine protein family
#1001Method of treating a pathological syndrome and a pharmaceutical agent
#1002Method of treating a pathological syndrome and a pharmaceutical agent
#1003Methods for Treating Ocular Inflammation by Neutralizing Cxcl10 Activity
#1004INFLAMMATORY MEDIATOR ANTAGONISTS
#1005CXCL13 antagonists and their use for the treatment of inflammatory diseases
#1006CMKLR regulation of adipogenesis and adipocyte metabolic function
#1007ANTIBODY VARIANTS
#1008Regulation of transcription factor, NF-IL6/LAP
#1009CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
#1010Immunocompetent Cell Activation Inhibitor and Use Thereof
#1011Cytokine protein family
#1012Vascular endothelial cell growth factor antagonists and uses thereof
#1013CYTOKINE PROTEIN FAMILY
#1014Cytokine zcytor17 ligand polypeptides
#1015Functional antibodies that specifically bind to the Chemerin receptor
#1016S100 Protein Inhibitors for Treating Leukemia
#1017Method of treating a pathological syndrome and a pharmaceutical agent
#1018CCR3 inhibition for ocular angiogenesis and macular degeneration
#1019LYMPHOCYTES; METHODS
#1020Methods for treating pulmonary fibrosis
#1021Cytokine zalpha11 ligand fusion proteins
#1022CARDIOTROPHIN-1 COMPOSITIONS AND METHODS FOR THE TREATMENT OF TUMOR
#1023Methods and compositions for prolonging elimination half-times of bioactive compounds
#1024CYTOKINE PROTEIN FAMILY
#1025Hmgb1 protein inhibitors for the regulation of smooth muscle cells and endothelial cells profileration
#1026EphA2 agonistic monoclonal antibodies and methods of use thereof
#1027Humanized antibodies against monocyte chemotactric proteins
#1028Cytokine protein family
#1029Molecular antigen arrays
#1030Cytokine protein family
#1031CYTOKINE PROTEIN FAMILY
#1032Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
#1033Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
#1034Antibodies to murine zcytor17 ligand
#1035CYTOKINE ZALPHA11 LIGAND
#1036CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1037CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1038Antagonist antibodies against GDF-8
#1039EphA2 agonistic monoclonal antibodies and methods of use thereof
#1040Chemokine PANEC-2 polypeptides and compositions and methods related thereto
#1041Murine ZCYTOR17 ligand polypeptides
#1042Dual variable domain immunoglobulin and uses thereof
#1043Cytokine zalpha11 ligand fusion proteins
#1044Cytokine zalpha11 ligand fusion proteins
#1045Method of isolating cytotoxic heterocomplex associated with multiple sclerosis
#1046Compositions and methods for treating hyperimmune response in the eye
#1047Method for expanding hematopoietic cells using cytokine zalpha11 ligand
#1048Compositions and methods for the diagnosis and treatment of immune disorders
#1049Cytokine zalpha11 ligand antibodies and methods of use
#1050METHOD OF TREATING FIBROSIS
#1051Methods of using cytokine zalpha11 ligand
#1052CYTOKINE ZALPHA11 LIGAND FUSION PROTEINS
#1053Cytokine zalpha11 ligand fusion proteins
#1054Method of use of cytokine ZALPHA11 ligand
#1055Method for treating tumors using anti-osteopontin antibodies
#1056CYTOKINE ZALPHA11 LIGAND ANTIBODIES
#1057ANTIBODY VARIANTS WITH FASTER ANTIGEN ASSOCIATION RATES
#1058Cytokine zalpha11 ligand antibodies
#1059Anti-interferon alpha antibodies
#1060Methods of inhibiting an immune response with anti-human endokine alpha antibodies
#1061Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1062Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
#1063Antibodies that specifically bind to chemokine beta-4
#1064Anti-CCL27 antibodies
#1065Monoclonal antibody and hybridoma producing the same
#1066Human antihuman MCP-1 antibody and antibody fragment thereof
#1067Method for generating monoclonal antibodies
#1068Antagonists of HMG1 for treating inflammatory conditions
#1069Prevention and treatment for GVHD
#1070Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)
#1071Human TSLP polynucleotides
#1072Methods of diagnosing sepsis by measuring HMG1
#1073Methods of treatment using antibodies to Neutrokine-alpha
#1074Compositions and methods for diagnosing and treating prostate cancer
#1075Methods of Treatment Using Antibodies to Neutrokine-alpha
#1076Method for preparing anti-MIF antibodies
#1077Novel TNF receptor death domain ligand proteins and inhibitors of ligand binding
#1078Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1079Agonist antibodies
#1080Compositions and methods of treating fibrotic disorders
#1081Antibodies to M-CSF
#1082Cytokine zcytor17 ligand polynucleotides
#1083Human chemotactic cytokine
#1084Method and compositions for immunotherapy of inflammatory and immune-dysregulatory diseases
#1085Modulators of EphA2 and EphrinA1 for the treatment of fibrosis-related disease
#1086Use of hmgb polypetides for increasing immune responses
#1087Human G-protein chemokine receptor (CCR5) HDGNR10
#1088Use of SDF-1 or G-CSF to improve myocardial function after ischemic injury
#1089Acetylated protein
#1090Osteopontin-coated surfaces and methods of use
#1091High affinity antibodies against HMGB1 and methods of use thereof
#1092Inflammatory mediator antagonists
#1093Cytokine protein family
#1094Method for determining MIF content
#1095Krib polynucleotides and polypeptides and uses thereof in the treatment of metabolic disorders
#1096Macrophage derived chemokine (MDC), MDC analogs, MDC inhibitor substances and uses thereof
#1097Compositions and methods useful for the diagnosis and treatment of heparin induced thrombocytopenia/thrombosis
#1098Human chemokine β-9 viral vectors
#1099Anti-MCP-1 antibodies, compositions, methods and uses
#1100Method for preventing HIV-1 infection of CD4+ cells
#1101Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
#1102Recombinant anti-osteopontin antibody and use thereof
#1103Antibodies against S100A8 and S100A9 proteins for modulating inflammatory reactions
#1104Remedies or preventives for rheumatoid arthritis
#1105Methods of inhibiting metastasis
#1106Antibodies to human chemokine beta-9
#1107Vascular endothelial cell growth factor antagonists and uses thereof
#1108Methods and compositions based on protein interactions with mastermind
#1109Therapeutic uses for MDC and MDC antagonists
#1110Methods and compositions for treating MCP-1 related pathologies
#1111Method for treating tumors using anti-osteopontin antibodies
#1112Method of inhibiting an activity of a gene product in a bone cell encoded by a nucleotide sequence comprising SEQ ID NO: 50
#1113Antibodies to chemokine Alpha-6
#1114Agonist antibodies
#1115Targeted transscleral controlled release drug delivery to the retina and choroid
#1116Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis
#1117Methods for treating neoplastic disease characterized by vascular endothelial growth factor D expression, for screening for neoplastic disease or metastatic risk, and for maintaining vascularization of tissue
#1118Method of treatment and bioassay involving macrophage migration inhibitory factor (MIF) as cardiac-derived myocardial depressant factor
#1119IP-10 antibodies and their uses
#1120Neutrokine-alpha fusion proteins
#1121Anti-TECK antibodies and methods of use therefor
#1122Combined use of anti-cytokine antibodies or antagonists and anti-CD20 for treatment of B cell lymphoma
#1123Compositions and methods for treating hyperimmune response in the eye
#1124Modulation of systemic memory T cell trafficking
#1125Method of using a cytokine that induces apoptosis
#1126Method of reducing neuropathic pain
#1127Human G-protein chemokine receptor (CCR5) HDGNR10
#1128Monoclonal antibodies against HMGB1
#1129Treatment of diabetic retinopathy
#1130EphA2 agonistic monoclonal antibodies and methods of use thereof
#1131Methods and materials for the inhibition of transplant rejection
#1132Removal of high molecular weight aggregates using hydroxyapatite chromatography
#1133Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1134Compositions and compounds for use as molecular adjuvant for a nicotine vaccine
#1135Assay method to monitor the response of anti-cytokine therapy
#1136Methods for using chemokine teck
#1137Antibodies to M-CSF
#1138Antibodies directed to monocyte chemo-attractant protein-1 (MCP-1) and uses thereof
#1139Determination of bone-sialoprotein in bodily fluids for oncological problems
#1140Methods for treating rheumatoid arthritis
#1141Vascular endothelial cell growth factor antagonists and uses thereof
#1142Method for treating fibrosis
#1143Lymphocytes; methods
#1144Cardiotrophin-1 compositions and methods for the treatment of tumor
#1145Antibodies against monocyte chemotactic proteins
#1146Therapeutic agents for multiple sclerosis
#1147Combination therapies for multiple sclerosis
#1148Methods of prevention and treatment of asthma, and allergic conditions
#1149Therapeutic methods for muscular or neuromuscular disorders
#1150EphA4 Antibodies
#1151Methods of prevention and treatment of asthama, and allergic conditions
#1152Methods of prevention and treatment of asthma, and allergic conditions
#1153Methods of modulating homing of T cell by interruption of chemokine/chemokine receptor signaling
#1154Peptides for use in treatment and diagnosis of type 1 diabetes